Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2009-09-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Photobiomodulation to Improve Cognition in TBI, With fMRI
NCT04230577
LED Therapy for the Treatment of Concussive Brain Injury
NCT02383472
LED Treatment to Improve Cognition and Promote Recovery in TBI
NCT02404402
Analysis of TCLT in TBI Patients: a Prospective, Randomized Controlled Trial
NCT02393079
Light Therapy for Moderate Traumatic Brain Injury
NCT02233413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will sign the Informed Consent Form(ICF) before Neuropsychological Screening test are administered. If the participant's neuropsychological screening test scores meet the Inclusion/Exclusion criteria and the participant meets the other Inclusion/Exclusion criteria, then he/she will be tested again on the tests that are part of the Neuropsychological Outcome Measures, the week before the Transcranial LED treatments, and during the week after the last LED treatment and again at one and two months after the last LED treatment. Treatment with Transcranial LED will be for 6 weeks. Participants will be treated three times per week: Monday, Wednesday and Friday. A total of 18 Transcranial LED treatments will be administered.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcranial LED Treatment
All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.
MedX Health Phototherapy (light therapy)
The treatment period is 6 weeks (3x per week) for a total of 18 Transcranial LED treatments. Each treatment session is 30 minutes each.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MedX Health Phototherapy (light therapy)
The treatment period is 6 weeks (3x per week) for a total of 18 Transcranial LED treatments. Each treatment session is 30 minutes each.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sustained a mild traumatic brain injury(mTBI) at least 6 months ago
* mTBI is defined as \< 30 minutes loss of consciousness and \<30 minutes, post trauma amnesia
* since the injury patient continues having problems with memory and thinking ability
Exclusion Criteria
* mTBI occured less than 6 months ago
* moderate to severe Traumatic Brain Injury (TBI)
* non-closed head injury
* presence of craniotomy, craniectomy, or ventriculoperitoneal shunt
* Non-English speaking subjects - Neuropsychological Tests only in English
* Neuropsychological Screening Test Scores not at least 2 SD below norm on one of the neuropsychological tests or not 1 SD below norm on at least two of the tests administered during screening)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spaulding Rehabilitation Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ross D. Zafonte, MD
Vice President Medical Affairs, Research and Education Spaulding Rehabilitation Network
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ross D Zafonte, DO
Role: PRINCIPAL_INVESTIGATOR
Spaulding Rehabilitation Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of low-level laser therapy in neurorehabilitation. PM R. 2010 Dec;2(12 Suppl 2):S292-305. doi: 10.1016/j.pmrj.2010.10.013.
Naeser MA, Saltmarche A, Krengel MH, Hamblin MR, Knight JA. Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg. 2011 May;29(5):351-8. doi: 10.1089/pho.2010.2814. Epub 2010 Dec 23.
Related Links
Access external resources that provide additional context or updates about the study.
Department of Physical Medicine and Rehabilitation at Spaulding Hospital - Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-P-001552
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.